Narrowband ultraviolet B (NB-UVB) phototherapy remains one of the most widely used and effective treatments for vitiligo worldwide. It works by stimulating melanocyte activity and suppressing the autoimmune response that destroys pigment cells. This article explores how NB-UVB works, who it helps, and what patients can realistically expect.
NB-UVB therapy uses a specific wavelength of ultraviolet light (311–313 nm) to penetrate the skin and activate surviving melanocytes — the cells responsible for producing pigment. Unlike older broadband UV treatments, NB-UVB is safer, more targeted, and associated with fewer side effects like burning or premature skin aging.
Who Is a Good Candidate?
NB-UVB is suitable for patients with:
- Non-segmental (generalized) vitiligo affecting multiple body areas
- Lesions on the face, trunk, and limbs (these respond best)
- Patients who have not responded adequately to topical treatments alone
It is generally not recommended for patients with a history of photosensitivity disorders or certain skin cancers.
How Does Treatment Work?
Sessions are typically conducted 2–3 times per week in a dermatologist's clinic or with a home unit prescribed by a physician. Each session lasts only seconds to a few minutes, gradually increasing in duration as the skin adapts. Most patients begin to see initial repigmentation after 20–30 sessions, with optimal results appearing after 6–12 months of consistent treatment.
What Areas Respond Best?
Research consistently shows that the face and neck respond most favorably to NB-UVB, with repigmentation rates exceeding 75% in some studies. Extremities — particularly the hands and feet — tend to be more resistant. This is important for patients to discuss with their dermatologist when setting expectations.
Combining NB-UVB with Other Therapies
Many dermatologists now recommend combining NB-UVB with:
- Topical calcineurin inhibitors (e.g., tacrolimus) for enhanced effect on sensitive areas
- Oral antioxidants (vitamin D, vitamin E, alpha-lipoic acid) to reduce oxidative stress
- JAK inhibitors (emerging combination protocols) for faster, more complete repigmentation
Side Effects to Know
Common side effects include temporary redness and itching after sessions. Long-term risks are minimal but include a slightly increased risk of skin aging and, in theory, sun sensitivity. Most patients tolerate treatment well with proper dosing.
Key Takeaways
- NB-UVB is the most evidence-backed phototherapy for vitiligo, approved by dermatology guidelines globally
- Face and neck areas show the highest repigmentation success rates
- Treatment requires patience — consistent sessions over 6–12 months are necessary
- Combination with topical tacrolimus can improve outcomes significantly
- Home NB-UVB units are available for motivated patients under medical supervision
